1-12 of 12
Yi Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT081: Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in Chinese patients (pts) with resectable NSCLC in CheckMate 816

Free
Changli Wang, Ke-Neng Chen, Qixun Chen, Lin Wu, Qun Wang, Xiaofei Li, Kejing Ying, Wenxiang Wang, Jian Zhao, Lunxu Liu, Junke Fu, Chunfang Zhang, Jichun Liu, Yi Hu, Mark M. Awad, Ives Ntambwe, Junliang Cai, Judith Bushong, Phuong Tran, Shun Lu
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT081.
https://doi.org/10.1158/1538-7445.AM2023-CT081
Published: 14 April 2023
View articletitled, Abstract CT081: Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in Chinese patients (pts) with resectable NSCLC in CheckMate 816
Journal Articles

Abstract CT544: Multi-omics analysis uncovers prognostic biomarkers and tumor ecosystem dynamics during toripalimab combined with nab-paclitaxel and s-1 as neoadjuvant therapy for esophageal squamous carcinoma: A single-center, open-label, single-arm phase 2 trial

Free
Guoqing Zhang, Jing Yuan, Chaohu Pan, Qing Xu, Xiaoli Cui, Jing Zhang, Minglu Liu, Zhigang Song, Liangliang Wu, Dongfang Wu, Bo Yang, Haitao Luo, Yi Hu, Shunchang Jiao
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT544.
https://doi.org/10.1158/1538-7445.AM2022-CT544
Published: 15 June 2022
View articletitled, Abstract CT544: Multi-omics analysis uncovers prognostic biomarkers and tumor ecosystem dynamics during toripalimab combined with nab-paclitaxel and s-1 as neoadjuvant therapy for esophageal squamous carcinoma: A single-center, open-label, single-arm phase 2 trial
Journal Articles

Abstract CT041: ORIENT-3: A randomized, open-label, phase 3 study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small-cell lung cancer (sqNSCLC)

Free
Yuankai Shi, Lin Wu, Xinmin Yu, Yan Wang, Puyuan Xing, Jianying Zhou, Airong Wang, Jianhua Shi, Yi Hu, Ziping Wang, Guangyu An, Yong Fang, Sanyuan Sun, Caicun Zhou, Changli Wang, Feng Ye, Xingya Li, Junye Wang, Mengzhao Wang, Yunpeng Liu, Yanqiu Zhao, Jifeng Feng
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT041.
https://doi.org/10.1158/1538-7445.AM2021-CT041
Published: 01 July 2021
View articletitled, Abstract CT041: ORIENT-3: A randomized, open-label, phase 3 study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small-cell lung cancer (sqNSCLC)
Journal Articles

Abstract 1601: Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Free
Guozhen Yang, Xiaodong Su, Hong Yang, Guangyu Luo, Chan Gao, Yating Zheng, Wenzhuan Xie, Mengli Huang, Yuezong Bai, Zhiqiang Wang, Peiqiang Cai, Haoqiang He, Jin Xiang, Muyuan Cai, Yijun Zhang, Chunhua Qu, Jianhua Fu, Qianwen Liu, Yi Hu, Jiudi Zhong, Yuanheng Huang, Qiyu Guo, Xu Zhang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1601.
https://doi.org/10.1158/1538-7445.AM2021-1601
Published: 01 July 2021
View articletitled, Abstract 1601: Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
Journal Articles

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

Available to Purchase
Yi Hu, Chun Yang, Tania Amorim, Mohsin Maqbool, Jenny Lin, Chen Li, Chuanfeng Fang, Li Xue, Ariel Kwart, Hua Fang, Mei Yin, Allison J. Janocha, Daisuke Tsuchimoto, Yusaku Nakabeppu, Xiaofeng Jiang, Alex Mejia-Garcia, Faiz Anwer, Jack Khouri, Xin Qi, Qing Y. Zheng, Jennifer S. Yu, Shan Yan, Thomas LaFramboise, Kenneth C. Anderson, Leal C. Herlitz, Nikhil C. Munshi, Jianhong Lin, Jianjun Zhao
Journal: Cancer Research
Cancer Res (2021) 81 (3): 713–723.
https://doi.org/10.1158/0008-5472.CAN-20-1010
Published: 01 February 2021
View articletitled, Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury
Open the PDF for Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury in another window
Includes: Supplementary data
Journal Articles

Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion

Available to Purchase
Qing-yun Chen, Yi-ni Li, Xin-yue Wang, Xu Zhang, Yi Hu, Lei Li, Da-qin Suo, Ke Ni, Zhuo Li, Jia-rong Zhan, Ting-ting Zeng, Ying-hui Zhu, Yan Li, Li-jia Ma, Xin-Yuan Guan
Journal: Cancer Research
Cancer Res (2020) 80 (24): 5583–5596.
https://doi.org/10.1158/0008-5472.CAN-20-1542
Published: 15 December 2020
View articletitled, Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion
Open the PDF for Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion in another window
Includes: Supplementary data
Journal Articles

Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

Free
Yunpeng Yang, Jie Huang, Tao Wang, Jianya Zhou, Jing Zheng, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong, Yanqiu Zhao, Yiping Zhang, Yong Song, Yi Hu, Zhuang Yu, Youling Gong, Yuan Chen, Feng Ye, Shucai Zhang, Lejie Cao, Yun Fan, Gang Wu, Yubiao Guo, Chengzhi Zhou, Kewei Ma, Jian Fang, Weineng Feng, Yunpeng Liu, Zhendong Zheng, Gaofeng Li, Ning Wu, Wei Song, Xiaoqing Liu, Shijun Zhao, Lieming Ding, Li Mao, Giovanni Selvaggi, Larry Zhu, Shanshan Xiao, Li Zhang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2997.
https://doi.org/10.1158/1538-7445.AM2020-2997
Published: 15 August 2020
View articletitled, Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial
Journal Articles

Abstract CT083: Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial

Free
Jie Wang, Yun Fan, Jun Zhao, Qiming Wang, Dingzhi Huang, Xingya Li, Jianhua Chen, Yong Fang, Zhijie Wang, Caicun Zhou, Yanping Hu, Haihua Yang, Yi Hu, Jianying Zhou, Xiaoyan Lin, Lifeng Wang, Yanjun Xu, Hanying Li
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT083.
https://doi.org/10.1158/1538-7445.AM2020-CT083
Published: 15 August 2020
View articletitled, Abstract CT083: Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial
Journal Articles

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Available to Purchase
Yi Hu, Huimin Liu, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert, Juraj Bodo, Gabriel Habermehl, Benjamin E. Russell, Wenjun Li, Marcia Chappell, Xiaofeng Jiang, Sarah L. Ondrejka, Eric D. Hsi, Jaroslaw P. Maciejewski, Qing Yi, Kenneth C. Anderson, Nikhil C. Munshi, Geyou Ao, Jason N. Valent, Jianhong Lin, Jianjun Zhao
Journal: Cancer Research
Cancer Res (2020) 80 (10): 2031–2044.
https://doi.org/10.1158/0008-5472.CAN-19-1077
Published: 15 May 2020
View articletitled, Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma
Open the PDF for Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract 3576: MALAT1 is essential for A-NHEJ pathway choice during B cell immunoglobulin class switch recombination

Free
Jianjun Zhao, Yi Hu, Jianhong Lin, Hua Fang
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3576.
https://doi.org/10.1158/1538-7445.AM2019-3576
Published: 01 July 2019
View articletitled, Abstract 3576: MALAT1 is essential for A-NHEJ pathway choice during B cell immunoglobulin class switch recombination
Journal Articles

IGF1R mediated activation of the autocrine TGFα loop requires the PI3K pathway but not the MAPK pathway

Free
Sandip Patil, Yi Hu, Michelle Vinci, Wenhui Li, Jennie Hauser, Lisa Humphrey, Michael Brattain
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3576.
Published: 01 May 2007
View articletitled, IGF1R mediated activation of the autocrine TGFα loop requires the PI3K pathway but not the MAPK pathway
Journal Articles

Seroepidemiology of Human T-Cell Lymphotropic Virus Type I Infection in Taiwan

Free
Chiu-Hwa Wang, Chien-Jen Chen, Chung-Yi Hu, San-Lin You, Chien-Ts Chu, Min-Ji Chou, Max Essex, William A. Blattner, Chen-Hui Liu, Czau-Siung Yang
Journal: Cancer Research
Cancer Res (1988) 48 (17): 5042–5044.
Published: 01 September 1988
View articletitled, Seroepidemiology of Human T-Cell Lymphotropic Virus Type I Infection in Taiwan
Open the PDF for Seroepidemiology of Human T-Cell Lymphotropic Virus Type I Infection in Taiwan in another window